Khiron Competitors

Delisted . USA . 
Stock . Khiron Life Sciences
KHRWFDelisted Stock  USD 0  0.00  0.00%   
Khiron Life Sciences competes with Inflection Point, Cedar Realty, Nasdaq, Yuexiu Real, and Viemed Healthcare; as well as few others. Analyzing Khiron Life competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Khiron Life to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Khiron Life competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Khiron Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.010.01
Details
Intrinsic
Valuation
LowRealHigh
0.0000.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Khiron Life. Your research has to be compared to or analyzed against Khiron Life's peers to derive any actionable benefits. When done correctly, Khiron Life's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Khiron Life Sciences.

Khiron Life Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Khiron Life and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Khiron and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Khiron Life Sciences does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
NMR
+ 0.84
CDR-PB
NMR
+ 0.83
IPXXU
NMR
+ 0.71
NDAQ
NDAQ
+ 0.7
IPXXU
CDR-PB
+ 0.68
IPXXU
NMR
+ 0.6
VMD
  
High negative correlations   
MMSI
- 0.89
IPXXU
MMSI
- 0.79
NMR
MMSI
- 0.79
NDAQ
MMSI
- 0.6
CDR-PB
MMSI
- 0.28
VMD
MMSI
- 0.0
YUXXF

Risk-Adjusted Indicators

There is a big difference between Khiron Pink Sheet performing well and Khiron Life Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Khiron Life's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Khiron Life Competitive Analysis

The better you understand Khiron Life competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Khiron Life's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Khiron Life's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
KHRWF IPXXU CDR-PB NDAQ YUXXF VMD NMR MMSI
 0.00 
 0 
Khiron
 0.28 
 10.58 
Inflection
 0.13 
 15.70 
Cedar
 0.18 
 61.09 
Nasdaq
 0.00 
 0.20 
Yuexiu
 2.81 
 8.06 
Viemed
 0.17 
 5.89 
Nomura
 1.27 
 74.18 
Merit
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Not too volatile
Very steady
Very steady
Somewhat reliable
Somewhat reliable
Very steady
Market Performance
(90 Days Performance)
Very Weak
Solid
Insignificant
Modest
Very Weak
Very Weak
OK
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Low
About Average
Very Low
Quite High
Low
Very Low
Very Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Under Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Buy
Not Available
Strong Buy
Strong Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Strong Sell
Strong Hold
Strong Sell
Hold
Strong Hold
Strong Hold
Current Ratio
3.49 X
N/A
1.78 X
0.96 X
1.13 X
2.34 X
1.40 X
2.35 X
Net Asset
42.27 M
N/A
1.02 B
32.3 B
43.86 B
154.1 M
47.77 T
2.33 B
Profit Margin
N/A
N/A
0.24 %
0.17 %
(0.07) %
0.06 %
0.08 %
0.08 %
EBITDA
(32.03 M)
N/A
12.99 M
1.44 B
1.41 B
38.09 M
1.36 T
223.22 M
Current Valuation
N/A
329.41 M
1.04 B
45.18 B
3.78 B
301.34 M
3.64 T
4.55 B
Operating Margin
N/A
N/A
0.18 %
0.30 %
0.53 %
0.11 %
0.20 %
0.10 %
Price To Book
N/A
N/A
N/A
3.27 X
N/A
2.78 X
0.85 X
3.51 X
Five Year Return
N/A
N/A
7.26 %
1.57 %
N/A
N/A
3.71 %
N/A
Retained Earnings
N/A
N/A
N/A
7.83 B
N/A
79.09 M
1.65 T
575.18 M
Current Asset
N/A
N/A
N/A
3.26 B
N/A
N/A
N/A
204 M
Beta
1.92
N/A
1.19
0.94
1.03
1.36
0.7
0.91
Number Of Employees
10
N/A
55
8.53 K
671
996
26.77 K
6.95 K
Shares Outstanding
N/A
N/A
N/A
575.76 M
4.78 B
38.76 M
2.97 B
58.06 M
Cash Flow From Operations
(20.4 M)
N/A
44.96 M
206 M
774.54 M
46.04 M
(974.75 B)
145.15 M
Annual Yield
N/A
N/A
0.12 %
0.01 %
0.11 %
N/A
N/A
N/A
Total Debt
705 K
N/A
455.72 M
10.87 B
14.73 B
10.27 M
11.74 T
891.36 M
Return On Equity
-0.45
N/A
-0.37
0.12
-0.0078
0.0971
0.0373
0.0805
Return On Asset
-0.25
N/A
0.0219
0.0433
0.0154
0.0713
0.0024
0.0399
Number Of Shares Shorted
N/A
644
29.29 K
4.75 M
N/A
406.21 K
2.17 M
1.98 M
Book Value Per Share
N/A
(0.41) X
(5.32) X
18.80 X
3.63 X
2.96 X
1,088 X
20.77 X
Current Liabilities
N/A
N/A
N/A
2.92 B
N/A
N/A
N/A
87.91 M
Total Asset
42.27 M
N/A
1.02 B
32.3 B
43.86 B
154.1 M
47.77 T
2.33 B
Debt To Equity
0.06 %
N/A
118.70 %
0.99 %
0.89 %
0.06 %
9.58 %
0.26 %
Short Ratio
N/A
0.54 X
2.86 X
1.03 X
N/A
1.48 X
0.78 X
4.21 X
Last Dividend Paid
N/A
N/A
0.13
0.86
0.17
N/A
20.0
N/A
Target Price
N/A
N/A
N/A
66.6
N/A
15.38
6.84
93.6
Shares Owned By Institutions
N/A
3.94 %
15.79 %
77.75 %
4.38 %
62.39 %
1.43 %
97.57 %
Market Capitalization
N/A
N/A
143.74 M
35.24 B
1.6 B
303.85 M
17.47 B
4.25 B
Price To Earning
N/A
N/A
181.85 X
10.92 X
8.84 X
29.88 X
8.00 X
956.67 X
Price To Earnings To Growth
N/A
N/A
N/A
1.98 X
N/A
N/A
0.85 X
1.91 X
Price To Sales
N/A
N/A
0.90 X
5.84 X
0.66 X
1.73 X
0.01 X
3.35 X
Net Income
(33.13 M)
N/A
(45.1 M)
1.06 B
674.56 M
10.43 M
91.68 B
94.41 M
Earnings Per Share
N/A
N/A
(4.39) X
2.08 X
0.03 X
0.25 X
0.24 X
1.62 X
Shares Owned By Insiders
N/A
N/A
N/A
10.73 %
46.87 %
12.71 %
N/A
2.43 %
Revenue
12.79 M
N/A
127.55 M
6.06 B
1.8 B
186.36 M
1.15 T
1.25 B
Working Capital
N/A
N/A
N/A
71 M
N/A
6.24 M
N/A
904.91 M
Cash And Equivalents
N/A
N/A
4.71 M
430 M
1.77 B
21.92 M
4.23 T
51.48 M
Cash Per Share
N/A
N/A
0.05 X
0.88 X
0.53 X
0.57 X
N/A
0.91 X
Gross Profit
N/A
N/A
81.1 M
3.58 B
1.3 B
84.68 M
1 T
519.1 M
Day Typical Price
0.0041
10.58
15.64
61.18
0.2
8.05
5.9
74.22
Accumulation Distribution
N/A
N/A
8.36
20754.0
N/A
6117.86
8579.36
8126.65
Market Facilitation Index
N/A
N/A
2.0E-4
N/A
N/A
0.0
N/A
0.0
Daily Balance Of Power
0.0
9.2 T
0.1111
(0.20)
0.0
0.5789
0.25
0.5813
Period Momentum Indicator
N/A
0.03
0.02
(0.11)
N/A
0.22
0.01
0.93
Rate Of Daily Change
1.0
1.0
1.0
1.0
1.0
1.03
1.0
1.01
Day Median Price
0.0041
10.58
15.61
61.23
0.2
8.05
5.9
74.24
Price Action Indicator
N/A
0.015
0.1
(0.19)
N/A
0.12
(0.01)
0.41
Coefficient Of Variation
606.89
373.19
883.34
939.49
N/A
3428.86
700.85
(1,488)
Mean Deviation
95.8
0.0758
2.15
0.8818
N/A
2.12
1.32
1.05
Jensen Alpha
39.99
0.0185
0.3325
0.0387
N/A
(0.07)
0.261
(0.19)
Total Risk Alpha
8.88
0.0058
(0.05)
(0.04)
N/A
(0.29)
0.0181
(0.29)
Sortino Ratio
0.9262
(0.31)
0.087
0.0304
N/A
(0)
0.1082
N/A
Downside Variance
1914.44
0.036
6.57
1.36
N/A
7.53
3.34
N/A
Standard Deviation
246.49
0.1136
2.76
1.17
N/A
2.82
2.01
1.42
Kurtosis
28.57
2.79
(0.12)
0.4985
N/A
0.5661
8.5
1.85
Potential Upside
164.49
0.2844
5.75
1.92
N/A
4.76
2.95
2.25
Treynor Ratio
5.24
0.8413
(0.80)
0.1196
N/A
0.0405
1.38
(0.10)
Maximum Drawdown
1437.52
0.6696
11.84
6.13
N/A
13.27
14.69
7.75
Variance
60757.87
0.0129
7.61
1.37
N/A
7.97
4.04
2.0
Market Risk Adjusted Performance
5.25
0.8513
(0.79)
0.1296
N/A
0.0505
1.39
(0.09)
Risk Adjusted Performance
0.1114
0.1208
0.0775
0.0703
N/A
0.0258
0.0948
(0.04)
Skewness
5.26
0.9394
0.2016
0.1267
N/A
0.0829
1.42
(0.30)
Semi Deviation
33.1
0.0
2.23
1.01
N/A
2.61
1.42
N/A
Information Ratio
0.1644
(0.52)
0.0809
0.0302
N/A
(0)
0.0983
(0.13)
Value At Risk
(74.00)
(0.1)
(4.35)
(2.00)
N/A
(5.33)
(3.43)
(1.83)
Expected Short fall
(159.63)
(0.20)
(2.44)
(0.90)
N/A
(2.41)
(1.44)
N/A
Downside Deviation
43.75
0.1898
2.56
1.17
N/A
2.74
1.83
N/A
Semi Variance
1095.79
(0.03)
4.97
1.02
N/A
6.8
2.03
N/A

Khiron Life Competition Performance Charts

Five steps to successful analysis of Khiron Life Competition

Khiron Life's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Khiron Life Sciences in relation to its competition. Khiron Life's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Khiron Life in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Khiron Life's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Khiron Life Sciences, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Khiron Life position

In addition to having Khiron Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Impulse Thematic Idea Now

Impulse
Impulse Theme
Large corporations operating in retail, broadcasting, energy, airlines and telecom sectors. The Impulse theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Impulse Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in Khiron Pink Sheet

If you are still planning to invest in Khiron Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Khiron Life's history and understand the potential risks before investing.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY